Caliper Discovery
Adversarial pharmacovigilance · Pre-registered · sha1-locked
🏠 Home
🔬 Findings
➕ Submit
🔭 Discover
📜 Ledger
ℹ About
☾
← RocSite
Discover — scan a drug or class for emergent signals
No specific adverse-event hypothesis required. The platform enumerates the top reactions and validates each.
Single drug
Drug class
Drug (generic name)
*
Use openFDA's canonical generic name. Brand names may not resolve.
Your email
(optional)
What happens:
The platform fetches every adverse-event report for this drug, ranks the top 20 reactions, and runs the disproportionality analysis on each. Pre-registration is locked at submission. Results publish to the signed ledger.
Scan this drug →
Drug class
*
— select a class —
Sglt2 Inhibitors (6 drugs)
Glp1 Agonists (7 drugs)
Anti Amyloid Mabs (3 drugs)
Kras G12C Inhibitors (2 drugs)
Btk Inhibitors (4 drugs)
S1P Modulators (5 drugs)
Cgrp Antagonists (8 drugs)
Pd1 Pdl1 Inhibitors (9 drugs)
Car T Therapies (6 drugs)
Trkb Modulators (3 drugs)
Fda Novel 2020 2024 (57 drugs)
Your email
(optional)
Heads-up:
A class scan runs the single-drug scan against every member of the class. For a class of 8 drugs this can take 10–20 minutes the first time (FAERS data gets cached after first fetch).
Scan this class →